Cargando…

Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?

Detalles Bibliográficos
Autores principales: Boyd, Kathleen A, Briggs, Andrew H, Paul, Jim, Iveson, Tim, Midgely, Rachel, Harkin, Andrea, Bates, Gaynor, Alexander, Laura, Cassidy, Jim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287757/
http://dx.doi.org/10.1186/1745-6215-12-S1-A41
_version_ 1782224736718159872
author Boyd, Kathleen A
Briggs, Andrew H
Paul, Jim
Iveson, Tim
Midgely, Rachel
Harkin, Andrea
Bates, Gaynor
Alexander, Laura
Cassidy, Jim
author_facet Boyd, Kathleen A
Briggs, Andrew H
Paul, Jim
Iveson, Tim
Midgely, Rachel
Harkin, Andrea
Bates, Gaynor
Alexander, Laura
Cassidy, Jim
author_sort Boyd, Kathleen A
collection PubMed
description
format Online
Article
Text
id pubmed-3287757
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32877572012-02-28 Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting? Boyd, Kathleen A Briggs, Andrew H Paul, Jim Iveson, Tim Midgely, Rachel Harkin, Andrea Bates, Gaynor Alexander, Laura Cassidy, Jim Trials Oral Presentation BioMed Central 2011-12-13 /pmc/articles/PMC3287757/ http://dx.doi.org/10.1186/1745-6215-12-S1-A41 Text en Copyright ©2011 Boyd et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Boyd, Kathleen A
Briggs, Andrew H
Paul, Jim
Iveson, Tim
Midgely, Rachel
Harkin, Andrea
Bates, Gaynor
Alexander, Laura
Cassidy, Jim
Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?
title Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?
title_full Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?
title_fullStr Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?
title_full_unstemmed Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?
title_short Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?
title_sort analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287757/
http://dx.doi.org/10.1186/1745-6215-12-S1-A41
work_keys_str_mv AT boydkathleena analysisofadverseeventsandqualityoflifedataforaneconomicevaluationofadjuvantchemotherapyincolorectalcancerwhencanwestopcollecting
AT briggsandrewh analysisofadverseeventsandqualityoflifedataforaneconomicevaluationofadjuvantchemotherapyincolorectalcancerwhencanwestopcollecting
AT pauljim analysisofadverseeventsandqualityoflifedataforaneconomicevaluationofadjuvantchemotherapyincolorectalcancerwhencanwestopcollecting
AT ivesontim analysisofadverseeventsandqualityoflifedataforaneconomicevaluationofadjuvantchemotherapyincolorectalcancerwhencanwestopcollecting
AT midgelyrachel analysisofadverseeventsandqualityoflifedataforaneconomicevaluationofadjuvantchemotherapyincolorectalcancerwhencanwestopcollecting
AT harkinandrea analysisofadverseeventsandqualityoflifedataforaneconomicevaluationofadjuvantchemotherapyincolorectalcancerwhencanwestopcollecting
AT batesgaynor analysisofadverseeventsandqualityoflifedataforaneconomicevaluationofadjuvantchemotherapyincolorectalcancerwhencanwestopcollecting
AT alexanderlaura analysisofadverseeventsandqualityoflifedataforaneconomicevaluationofadjuvantchemotherapyincolorectalcancerwhencanwestopcollecting
AT cassidyjim analysisofadverseeventsandqualityoflifedataforaneconomicevaluationofadjuvantchemotherapyincolorectalcancerwhencanwestopcollecting